Articles tagged with Peritonitis
Scientists have discovered that immune cells shed their glycocalyx layer to move into tissues, changing the understanding of inflammatory skin diseases like psoriasis. This finding may lead to new approaches in developing drugs targeting immune cell movement and treating infections and inflammatory diseases.
Researchers identified a new drug treatment option for peritonitis in patients on peritoneal dialysis, showing that a low dosage of ceftazidime and avibactam is sufficient to treat the infection. The study's findings could help gain control over peritonitis in patients with difficult-to-treat germs.
The study found a significant decline in peritoneal dialysis-associated peritonitis rates over time, with consistent differences in risk by race and age. The decline suggests improvements in clinical practice and highlights the importance of uniform coding standards to identify additional risk factors.
The 2022 AAFP/EveryCat Feline Infectious Peritonitis Diagnosis Guidelines provide essential information for veterinarians to diagnose FIP, a fatal viral disease affecting young cats. The guidelines offer helpful tips, images, and tables to assist clinicians in recognizing FIP symptoms.
A protocol-based potassium supplementation strategy resulted in a longer time to the first peritonitis episode and a lower hazard ratio of peritonitis compared to reactive supplementation. This approach also improved PD-related outcomes by significantly reducing the risk of peritonitis.
Researchers found that male mice recruit more white blood cells to the site of inflammation than females, highlighting the importance of sex differences in inflammatory responses. This discovery has implications for how we design and interpret experiments and evaluate anti-inflammatory therapeutics.
A recent study suggests that peritonitis, a common infection in dialysis patients on peritoneal dialysis, may be linked to premature death. Researchers found that patients were more likely to develop peritonitis during the final month before their death, and even six times more so during the 30 days prior to their death.
A recent study published in The Lancet found that treating acute appendicitis with antibiotics is not as effective as surgically removing the appendix. In the study, patients who received antibiotics were more likely to develop post-intervention peritonitis, a serious inflammation of the abdominal cavity.
A Canadian study found First Nations people on peritoneal dialysis experience higher rates of peritonitis and mortality, despite living in either rural or urban areas. The high prevalence of diabetes and obesity among First Nations populations contributes to the growth of kidney disease and renal failure, necessitating dialysis care.
Researchers compared on-demand and planned relaparotomy strategies for patients with severe secondary peritonitis. The study found that on-demand strategy reduced health care utilization, ICU stays, and hospital stays, while also decreasing direct medical costs.
A blood marker, procalcitonin, helps identify patients at increased risk of organ failure and death due to abdominal infections. Procalcitonin levels can predict multi-organ dysfunction syndrome and overall prognosis in patients with secondary peritonitis.
Scientists at Cardiff University have developed a new protein to help manage acute infection and inflammation. The protein has been jointly investigated by Dr Simon Jones and Dr Nicholas Topley for several years, revealing its potential in treating chronic disorders such as rheumatoid arthritis and bacterial peritonitis.